196 related articles for article (PubMed ID: 20977377)
1. Restless legs syndrome and near-infrared light: An alternative treatment option.
Mitchell UH; Myrer JW; Johnson AW; Hilton SC
Physiother Theory Pract; 2011 Jul; 27(5):345-51. PubMed ID: 20977377
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two infrared devices in their effectiveness in reducing symptoms associated with RLS.
Mitchell UH; Johnson AW; Myrer B
Physiother Theory Pract; 2011 Jul; 27(5):352-9. PubMed ID: 20950168
[TBL] [Abstract][Full Text] [Related]
3. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS.
Rajaram SS; Shanahan J; Ash C; Walters AS; Weisfogel G
Sleep Med; 2005 Mar; 6(2):101-6. PubMed ID: 15716213
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
Giorgi L; Ritchie SY; Kirsch JM
Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
Allen RP; Ritchie SY
Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
[TBL] [Abstract][Full Text] [Related]
7. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting.
Abetz L; Arbuckle R; Allen RP; Garcia-Borreguero D; Hening W; Walters AS; Mavraki E; Kirsch JM
Sleep Med; 2006 Jun; 7(4):340-9. PubMed ID: 16713344
[TBL] [Abstract][Full Text] [Related]
8. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
Kushida CA; Geyer J; Tolson JM; Asgharian A
Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346
[TBL] [Abstract][Full Text] [Related]
9. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
Benes H
Sleep Med; 2006 Jan; 7(1):31-5. PubMed ID: 16194624
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallström Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
Mov Disord; 2007 Jan; 22(2):213-9. PubMed ID: 17133582
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
Nomura T; Inoue Y; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
[TBL] [Abstract][Full Text] [Related]
12. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar NG; Ratcliffe SJ
Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
[TBL] [Abstract][Full Text] [Related]
13. Effects of melatonin and bright light administration on motor and sensory symptoms of RLS.
Whittom S; Dumont M; Petit D; Desautels A; Adam B; Lavigne G; Montplaisir J
Sleep Med; 2010 Apr; 11(4):351-5. PubMed ID: 20226733
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
[TBL] [Abstract][Full Text] [Related]
15. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study.
Sakkas GK; Hadjigeorgiou GM; Karatzaferi C; Maridaki MD; Giannaki CD; Mertens PR; Rountas C; Vlychou M; Liakopoulos V; Stefanidis I
ASAIO J; 2008; 54(2):185-90. PubMed ID: 18356653
[TBL] [Abstract][Full Text] [Related]
16. Bupropion and restless legs syndrome: a randomized controlled trial.
Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
[TBL] [Abstract][Full Text] [Related]
17. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
19. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.
Delgado Rodrigues RN; Alvim de Abreu E Silva Rodrigues AA; Pratesi R; Krieger J
Sleep Med; 2006 Apr; 7(3):235-9. PubMed ID: 16564217
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.
Tison F; Crochard A; Léger D; Bouée S; Lainey E; El Hasnaoui A
Neurology; 2005 Jul; 65(2):239-46. PubMed ID: 16043793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
